A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Clinical trial NCT05077137 · RECRUITING
Trial details
- NCT number
- NCT05077137
- Sponsor
- Duke University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2027-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.